United States · Funded startup

Who invested in GRIP Molecular Technologies

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised this month

Funding summaryUpdated 7 Nov 2026

$12Mraised across 1 round since 2026, from 1 source

Latest round
Round, $12MOct 2026
Investors
0
See who backed them

The rounds

  1. Oct 2026
    Round$12M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $12M sold, first sale Oct 2026

Funding filed with regulators

GRIP Molecular Technologies filed 4 raises, $21M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Oct 2026$12M41 investorsof $21M offeredSEC Form D
  2. May 2023$500K1 investordebt, options, securities on exerciseSEC Form D
  3. Nov 2020$100K1 investorequitySEC Form D
  4. Dec 2019$8.8M41 investorsof $12M offeredSEC Form D

Founders and team

From GRIP Molecular Technologies's own website: 1 founder, 3 on the team.

Bruce Batten Ph.D.Founder | CSO
  • Edward GillenCEO | Cco
  • Richard MinicusCFO
  • Edward LudwigBoard Chairman

Quick answers about GRIP Molecular Technologies

How much has GRIP Molecular Technologies raised?

GRIP Molecular Technologies has raised $12M across 1 round since 2026.

When did GRIP Molecular Technologies last raise?

GRIP Molecular Technologies's most recent round, $12M, was in Oct 2026.

What was GRIP Molecular Technologies's biggest round?

Its most recent round, $12M in Oct 2026, is also its largest on record.

Where is GRIP Molecular Technologies based?

GRIP Molecular Technologies is based in the United States.

Companies like GRIP Molecular Technologies

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.